JTE-151 | m-entrepreneurship.com

Product Name :
JTE-151

Search keywords :
JTE-151

drugId :
null

Target Vo:
Nuclear receptor ROR-gamma

Target Vo Short Name :
RORG

Moa_Name:
Nuclear receptor ROR-gamma antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Japan Tobacco (Hong Kong) Ltd

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Hypersensitivity

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD19 Antibody
RHEB Antibody
Insulin Receptor Beta Antibody: Insulin Receptor Beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 156 kDa, targeting to Insulin Receptor Beta. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Rat.

Author: Betaine hydrochloride

Related Posts